Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 4
392
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Anti-inflammatory flavanol glycosides from Saraca asoca bark

, , , , &
Pages 489-492 | Received 10 Dec 2014, Accepted 20 Feb 2015, Published online: 23 Mar 2015
 

Abstract

Saraca asoca (Roxb.) de Wilde, a common tree of India, is popularly used in the Ayurvedic and modern herbal systems of medicine for genito-urinary problems of women. Considering the reported antimicrobial or anti-inflammatory effect of S. asoca bark against such infections, we studied the anti-inflammatory activity-guided isolation of active compounds from methanol extract. The methanol extract of bark has yielded 10 compounds out of which 3′-deoxyepicatechin-3-O-β-d-glucopyranoside (6) and 3′-deoxycatechin-3-O-α-l-rhamnopyranoside (8) have been found to be in vitro and in vivo active. 3′,5-Dimethoxy epicatechin (3), 3′-deoxyepicatechin-3-O-β-d-glucopyranoside (6), 3′-deoxycatechin-3-O-α-l-rhamnopyranoside (8) and epigallocatechin (9) are being reported for the first time from S. asoca.

Acknowledgements

The authors are thankful to DBT, New Delhi for awarding a research grant to carry out this work and Prof. Vasudeva R., College of Forestry, Sirsi (University of Agricultural Sciences, Dharwad), India for providing the plant material. Director CSIR-CIMAP, Lucknow and CSIR-CDRI, Lucknow are thanked for providing the facilities.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.